{
  "patient_id": "CDME",
  "processing_timestamp": "2025-08-12T19:13:16.616362",
  "guideline_version": "ADA 2023",
  "clinical_alerts": [
    {
      "message": "Diabetes diagnosed: A1C 7% (\u22656.5%)",
      "priority": "critical",
      "category": "diagnosis",
      "evidence": "ADA 2023 Table 2.2: A1C \u22656.5% diagnostic for diabetes",
      "action_required": true,
      "guideline_reference": "ADA 2023 Section 2"
    },
    {
      "message": "Elevated LDL 165 mg/dL in diabetes - target <70",
      "priority": "warning",
      "category": "cardiovascular",
      "evidence": "ADA 2023 Section 10: LDL targets for diabetes",
      "action_required": true,
      "guideline_reference": ""
    },
    {
      "message": "A1C monitoring: Check every 6 months if stable at target",
      "priority": "info",
      "category": "monitoring",
      "evidence": "ADA 2023 Section 6.1: Biannual A1C if meeting goals",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Annual kidney function screening: eGFR and urine albumin",
      "priority": "info",
      "category": "monitoring",
      "evidence": "ADA 2023 Section 11.1a: Annual kidney screening",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Annual comprehensive eye examination recommended",
      "priority": "info",
      "category": "monitoring",
      "evidence": "ADA 2023 Section 12.5: Annual diabetic retinopathy screening",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Annual comprehensive foot examination recommended",
      "priority": "info",
      "category": "monitoring",
      "evidence": "ADA 2023 Section 12.21: Annual foot risk assessment",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Diabetes Self-Management Education and Support (DSMES) referral recommended",
      "priority": "info",
      "category": "education",
      "evidence": "ADA 2023 Section 5.2: DSMES at diagnosis and annually",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Medical Nutrition Therapy (MNT) referral recommended",
      "priority": "info",
      "category": "lifestyle",
      "evidence": "ADA 2023 Section 5: MNT by registered dietitian",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Physical activity: \u2265150 min/week moderate-intensity aerobic activity",
      "priority": "info",
      "category": "lifestyle",
      "evidence": "ADA 2023 Section 5.29: Physical activity recommendations",
      "action_required": false,
      "guideline_reference": ""
    }
  ],
  "medication_recommendations": [
    {
      "medication_class": "Statin",
      "specific_agents": [
        "atorvastatin",
        "rosuvastatin"
      ],
      "rationale": "High-intensity statin for diabetes CV protection",
      "contraindications": [
        "Active liver disease",
        "Pregnancy"
      ],
      "monitoring_required": [
        "Liver function tests",
        "CK if symptoms"
      ],
      "ada_reference": "ADA 2023 Section 10.18-10.26"
    },
    {
      "medication_class": "ACE inhibitor or ARB",
      "specific_agents": [
        "lisinopril",
        "enalapril",
        "losartan",
        "valsartan"
      ],
      "rationale": "Kidney protection in diabetes",
      "contraindications": [
        "Bilateral renal artery stenosis",
        "Hyperkalemia"
      ],
      "monitoring_required": [
        "Serum creatinine",
        "Serum potassium"
      ],
      "ada_reference": "ADA 2023 Section 11.4a"
    },
    {
      "medication_class": "Metformin",
      "specific_agents": [
        "metformin immediate-release",
        "metformin extended-release"
      ],
      "rationale": "First-line therapy for type 2 diabetes",
      "contraindications": [
        "eGFR <30",
        "Metabolic acidosis",
        "Severe heart failure"
      ],
      "monitoring_required": [
        "Kidney function",
        "Vitamin B12 levels"
      ],
      "ada_reference": "ADA 2023 Section 9"
    }
  ],
  "treatment_goals": [
    {
      "parameter": "A1C",
      "target_value": "<7.0%",
      "rationale": "Standard A1C target for most nonpregnant adults",
      "priority": "high"
    },
    {
      "parameter": "Preprandial glucose",
      "target_value": "80-130 mg/dL",
      "rationale": "ADA 2023 standard preprandial target",
      "priority": "standard"
    },
    {
      "parameter": "Postprandial glucose",
      "target_value": "<180 mg/dL",
      "rationale": "ADA 2023 standard postprandial target",
      "priority": "standard"
    }
  ],
  "summary": "1 critical findings requiring action; 3 medication recommendations; 3 individualized treatment targets",
  "next_actions": [
    "Initiate comprehensive diabetes care plan",
    "Review and initiate appropriate diabetes medications",
    "Schedule recommended monitoring and screening tests",
    "Refer for diabetes education and lifestyle interventions"
  ]
}